Low-dose of benznidazole promotes therapeutic cure in experimental chronic Chagas' disease with absence of parasitism in blood, heart and colon.
dc.contributor.author | Melo, Luísa Helena Perin de | |
dc.contributor.author | Fonseca, Kátia da Silva | |
dc.contributor.author | Carvalho, Thaís Vieira de | |
dc.contributor.author | Carvalho, Lívia Mendes | |
dc.contributor.author | Madeira, João Vitor | |
dc.contributor.author | Medeiros, Luciana da Fonseca | |
dc.contributor.author | Molina, Israel | |
dc.contributor.author | Oliveira, Rodrigo Corrêa de | |
dc.contributor.author | Carneiro, Cláudia Martins | |
dc.contributor.author | Vieira, Paula Melo de Abreu | |
dc.date.accessioned | 2020-04-28T14:53:02Z | |
dc.date.available | 2020-04-28T14:53:02Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Studies suggest that the dose of the standard benznidazole (BNZ) treatment regimen might be too high. We investigated the efficacy of BNZ 20 and 40 mg/kg/day compared with standard dose (100 mg/kg/day) to induce cure in mice infected with Trypanosoma cruzi Y strain in the acute and chronic phases of Chagas' disease. Our findings indicate that an experimental treatment with a BNZ low-dose (40 mg/kg/day) is similarly effective as the usual dose in the chronic mice model (100% of cure). In addition, the treatment in the chronic model of Chagas' disease presented better results than the acute model and colon appears to be a key tissue when it comes to evaluating treatment efficacy compared to blood and heart. Therefore, our data suggest the reconsideration of the current therapy, mainly in the chronic phase of the disease. | pt_BR |
dc.identifier.citation | MELO, L. H. P. et al. Low-dose of benznidazole promotes therapeutic cure in experimental chronic Chagas' disease with absence of parasitism in blood, heart and colon. Experimental Parasitology, v. 210, p. 107834, mar. 2020. Disponível em: <https://www.sciencedirect.com/science/article/pii/S001448941930503X?via%3Dihub>. Acesso em: 10 fev. 2020. | pt_BR |
dc.identifier.doi | https://doi.org/10.1016/j.exppara.2020.107834 | pt_BR |
dc.identifier.issn | 0902-449 | |
dc.identifier.uri | http://www.repositorio.ufop.br/handle/123456789/12116 | |
dc.identifier.uri2 | https://www.sciencedirect.com/science/article/pii/S001448941930503X?via%3Dihub | pt_BR |
dc.language.iso | en_US | pt_BR |
dc.rights | restrito | pt_BR |
dc.subject | Trypanosoma cruzi | pt_BR |
dc.subject | Treatment | pt_BR |
dc.title | Low-dose of benznidazole promotes therapeutic cure in experimental chronic Chagas' disease with absence of parasitism in blood, heart and colon. | pt_BR |
dc.type | Artigo publicado em periodico | pt_BR |
Arquivos
Pacote Original
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- ARTIGO_LowDoseBenznidazole.pdf
- Tamanho:
- 351.41 KB
- Formato:
- Adobe Portable Document Format
Licença do Pacote
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- license.txt
- Tamanho:
- 924 B
- Formato:
- Item-specific license agreed upon to submission
- Descrição: